Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: Non-invasive Ventilation Improves Lung Function in CF Patients But Not Survival, Study Finds My Search for Happier, Healthier Work Phase 2 Trial Testing SPI-1005 for Ototoxicity in CF Patients Moving Forward Non-invasive Ventilation Improves Lung Function in CF Patients But Not Survival, Study Finds Jan 18, 2019 07:00 am | Vijaya Iyer A reassessment of U.K. medical records showed that in cystic fibrosis (CF) patients, breathing support provided by gas inhalation, through a face or nasal mask, helps improve lung function but not survival, researchers report. The study “Non-invasive ventilation and clinical outcomes in cystic fibrosis: Findings from the UK CF registry” was published in the Journal […] The post Non-invasive Ventilation Improves Lung Function in CF Patients But Not Survival, Study Finds appeared first on Cystic Fibrosis News Today. Read More My Search for Happier, Healthier Work Jan 17, 2019 09:00 am | Elly Aylwin-Foster Hello there, and welcome to my column! This is a place to talk shop. Work. Jobs. Careers. Whichever term you prefer. In the not-too-distant past, I was a wide-eyed, coffee-swilling exec with a penchant for checked trousers. I worked in a trendy digital agency in London. (Trendy enough to have the company name hoisted above […] The post My Search for Happier, Healthier Work appeared first on Cystic Fibrosis News Today. Read More Phase 2 Trial Testing SPI-1005 for Ototoxicity in CF Patients Moving Forward Jan 17, 2019 07:00 am | Santiago Gisler Sound Pharmaceuticals (SPI) has enrolled its first-patient-in — meaning the first subject meeting the criteria for inclusion and exclusion of a clinical study — in a Phase 2 trial testing SPI-1005 for the prevention and treatment of tobramycin-induced ototoxicity in cystic fibrosis (CF) patients, the company announced. Tobramycin is an intravenous (into-the-vein) antibiotic treatment prescribed for […] The post Phase 2 Trial Testing SPI-1005 for Ototoxicity in CF Patients Moving Forward appeared first on Cystic Fibrosis News Today. Read More   Recent News CFF’s Preston Campbell: 2019 is a ‘Pivotal Year’ for CF Therapies Transplant Is Horrendous in the Beginning — You’re Not Abnormal Immunotherapy May Be Promising Strategy to Treat Chronic Infections of P. aeruginosa in CF Patients Let’s Use the Cystic Fibrosis News Today Forums for Empowerment Eluforsen Improves CFTR Protein Function in CF Patients with F508del Mutations, Phase 1 Trial Shows